Apelin-to-total cholesterol ratio predicts long-term major adverse cardiovascular events in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention: a retrospective cohort analysis
Abstract Background Despite advancements in ST-segment elevation myocardial infarction (STEMI) management, residual risks of major adverse cardiovascular events (MACE) persist. Apelin, a cardioprotective peptide with anti-inflammatory properties, and total cholesterol (TC), a key atherogenic factor,...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-025-04949-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|